HC Wainwright & Co. Reiterates Buy on Rockwell Medical, Maintains $11 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a 'Buy' rating on Rockwell Medical (NASDAQ:RMTI) and maintained a price target of $11.
October 04, 2023 | 10:20 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rockwell Medical's stock rating has been reiterated as 'Buy' by HC Wainwright & Co. with a maintained price target of $11.
The reiteration of the 'Buy' rating and maintenance of the price target by a reputable analyst could potentially boost investor confidence in Rockwell Medical, leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100